MIT vs DNR in induction-consolidation chemotherapy-The value of low-dose cytarabine for maintenance of remission and an assessment of prognostic factors in AML in the elderly : Final report of the leukemia cooperative group of EORTC and HOVON randomized phase III study AML9

• LOWENBERG

収録刊行物

• J Clin Oncol

  J Clin Oncol 16 872-881, 1998

詳細情報

• CRID: 1572824499230604160
• NII論文ID: 10005901099
• NII書誌ID: AA10638385
• データソース種別:
  • CiNii Articles